Who is WATCHMANTM For?
1. For contraindications, refer to Instructions for use of anticoagulant drugs. NOACs (dabigatran, rivaroxaban, and apixaban) are not recommended in patients with severe renal impairment (CrCl <30 mL/min) - ESC guideline 2016.
2. Transient Ischemic Attack
3. Examples: difficulties to stabilize INR (International Normalized Ratio) in the therapeutic range, compliance issues, drug discontinuation.
4. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. Camm AJ et al. European Heart Journal 2012;33:2719-2747.
CAUTION: The law restricts these devices to sale by our on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device.
Information for the use only in countries with applicable health authority product registrations. Information contained herein is for distribution outside the U.S., Japan and France.